Open access
Aug 2026
Single-cell and in vivo profiling reveal heterogeneous and organ-specific CRISPR-Cas9 off-target and translocation outcomes
It is shown that off-target editing and translocations vary widely between individual cells and organs, motivating the development of more sensitive and organ-specific safety assays for CRISPR therapies.
Alexandra Madsen, Niklas Selfjord, M. Martinez-Lage et al.
· Nature Communications · 0 citations